Skip to main content
Clinical Trials/IRCT20230429058021N1
IRCT20230429058021N1
Recruiting
未知

Clinical trial of the decellularized amniotic membrane for dressing of skin wounds

Sina Mehr Fajr Co.0 sites60 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Sina Mehr Fajr Co.
Enrollment
60
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Sina Mehr Fajr Co.

Eligibility Criteria

Inclusion Criteria

  • Patients with skin wounds (second degree burn trauma) after entering the hospital.

Exclusion Criteria

  • Cases such as having severe vascular lesions, active or latent infection, or uncontrolled infection at the wound site can prevent the effectiveness of this allograft.
  • Oposamniohyl should not be used to treat lesions that do not have a definitive diagnosis.
  • In patients with metabolic, heart, kidney, liver, blood, autoimmune or any other major diseases, this product should not be used without the permission of the attending physician.

Outcomes

Primary Outcomes

Not specified

Similar Trials